drugset / Trial / NCT07668180
A Study to Evaluate the Efficacy and Safety of IN-207907 Injection in Elderly Patients With Sarcopenia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The goal of this clinical trial is to learn if intervention can treat sarcopenia in the elderly. Researchers will compare IN-207907 120 mg, 240 mg, 360 mg and placebo to see if SPPB score improves.
Timeline
- Start
- 2026-09
- Primary completion
- 2028-02
- Completion
- 2028-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IN-207907 | Unknown | 120 mg | Intravenous |
| Subject | IN-207907 | Unknown | 240 mg | Intravenous |
| Subject | IN-207907 | Unknown | 360 mg | Intravenous |